News - Phagenesis

May, 2020

New guidelines for neurogenic dysphagia published by the German Society of Neurology (DGN) – Should recommendation (S1/ grade B) for pharyngeal electrical stimulation

April, 2020

The protocol for the promising PHINEST study was published in Medicine

January, 2020

Phagenesis Receives FDA Breakthrough Designation For Its Phagenyx® System FDA’s Breakthrough Device Designation Program allows for priority review of the Phagenyx® System

July, 2019

Promising results of Phagenyx® treatment in Orally Intubated ICU Patients with Dysphagia

July, 2019

1st patient recruited and randomised in PhINEST, a new RCT to confirm the positive outcomes of Phagenyx® treatment for patients with Post-Extubation Dysphagia

September, 2018

Multicentre randomised controlled trial confirms the significant benefits of Phagenyx® treatment for tracheostomised stroke patients with dysphagia